Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.48, $0.10 better than the analyst estimate of $0.38. Revenue for the quarter came in at $194 million versus the consensus estimate of $192.05 million.

GUIDANCE:

Repligen sees FY2026 EPS of $1.97-$2.05, versus the consensus of $1.97.

For earnings history and earnings-related data on Repligen (RGEN) click here.